Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Saunders

Showing results (161-170 of 276) with videos related to

Pageof 28
Sort By:
Sexually Transmitted Infections|November 14, 2024
Qualitative exploration of the barriers and facilitators to community pharmacy PrEP delivery for UK pharmacists and underserved community members using the COM-B model of behaviour changeChina Harrison, Hannah Family, Joanna Kesten, et al.
Bioorganic & Medicinal Chemistry Letters|November 7, 2002
A novel synthesis of 7-aryl-8-fluoro-pyrrolo[1,2-a]pyrimid-4-ones as potent, stable GnRH receptor antagonistsFabio C Tucci, Yun-Fei Zhu, Zhiqiang Guo, et al.
Developing World Bioethics|August 2, 2019
European Electronic Personal Health Records initiatives and vulnerable migrants: A need for greater ethical, legal and social safeguardsOliver Feeney, Gabriele Werner-Felmayer, Helena Siipi, et al.
Physical Review Letters|April 18, 2025
Chiral Superfluid Helium-3 in the Quasi-Two-Dimensional LimitPetri J Heikkinen, Lev V Levitin, Xavier Rojas, et al.
Bioorganic & Medicinal Chemistry Letters|August 18, 2005
Optimization of piperazinebenzylamines with a N-(1-methoxy-2-propyl) side chain as potent and selective antagonists of the human melanocortin-4 receptorJoseph Pontillo, Dragan Marinkovic, Joe A Tran, et al.
Bioorganic & Medicinal Chemistry Letters|July 20, 2002
Design, synthesis and structure-activity relationships of novel imidazolo[1,2-a]pyrimid-5-ones as potent GnRH receptor antagonistsTimothy D Gross, Yun Fei Zhu, John Saunders, et al.
Bioorganic & Medicinal Chemistry Letters|April 15, 2004
Synthesis and structure-activity relationships of (R)-1-alkyl-3-[2-(2-amino)phenethyl]-5-(2-fluorophenyl)-6-methyluracils as human GnRH receptor antagonistsMartin W Rowbottom, Fabio C Tucci, Yun-Fei Zhu, et al.
Bioorganic & Medicinal Chemistry Letters|February 3, 2005
Bis(aminopyrrolidine)-derived ureas (APUs) as potent MCH1 receptor antagonistsJonathan Grey, Brian Dyck, Martin W Rowbottom, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|August 16, 2022
Joint European policy on the COVID-19 risks for people with mental disorders: An umbrella review and evidence- and consensus-based recommendations for mental and public healthBenedetta Vai, Mario Gennaro Mazza, Casanova Dias Marisa, et al.
Health Promotion Journal of Australia : Official Journal of Australian Association of Health Promotion Professionals|September 5, 2020
Supporting patients to be involved in decisions about their health and care: Development of a best practice health literacy App for Australian adults living with Chronic Kidney DiseaseDanielle Marie Muscat, Kelly Lambert, Heather Shepherd, et al.
Pageof 28

Showing results (161-170 of 276) with videos related to

Sort By:
Pageof 28
Sexually Transmitted Infections|November 14, 2024
Qualitative exploration of the barriers and facilitators to community pharmacy PrEP delivery for UK pharmacists and underserved community members using the COM-B model of behaviour changeChina Harrison, Hannah Family, Joanna Kesten, et al.
Bioorganic & Medicinal Chemistry Letters|November 7, 2002
A novel synthesis of 7-aryl-8-fluoro-pyrrolo[1,2-a]pyrimid-4-ones as potent, stable GnRH receptor antagonistsFabio C Tucci, Yun-Fei Zhu, Zhiqiang Guo, et al.
Developing World Bioethics|August 2, 2019
European Electronic Personal Health Records initiatives and vulnerable migrants: A need for greater ethical, legal and social safeguardsOliver Feeney, Gabriele Werner-Felmayer, Helena Siipi, et al.
Physical Review Letters|April 18, 2025
Chiral Superfluid Helium-3 in the Quasi-Two-Dimensional LimitPetri J Heikkinen, Lev V Levitin, Xavier Rojas, et al.
Bioorganic & Medicinal Chemistry Letters|August 18, 2005
Optimization of piperazinebenzylamines with a N-(1-methoxy-2-propyl) side chain as potent and selective antagonists of the human melanocortin-4 receptorJoseph Pontillo, Dragan Marinkovic, Joe A Tran, et al.
Bioorganic & Medicinal Chemistry Letters|July 20, 2002
Design, synthesis and structure-activity relationships of novel imidazolo[1,2-a]pyrimid-5-ones as potent GnRH receptor antagonistsTimothy D Gross, Yun Fei Zhu, John Saunders, et al.
Bioorganic & Medicinal Chemistry Letters|April 15, 2004
Synthesis and structure-activity relationships of (R)-1-alkyl-3-[2-(2-amino)phenethyl]-5-(2-fluorophenyl)-6-methyluracils as human GnRH receptor antagonistsMartin W Rowbottom, Fabio C Tucci, Yun-Fei Zhu, et al.
Bioorganic & Medicinal Chemistry Letters|February 3, 2005
Bis(aminopyrrolidine)-derived ureas (APUs) as potent MCH1 receptor antagonistsJonathan Grey, Brian Dyck, Martin W Rowbottom, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|August 16, 2022
Joint European policy on the COVID-19 risks for people with mental disorders: An umbrella review and evidence- and consensus-based recommendations for mental and public healthBenedetta Vai, Mario Gennaro Mazza, Casanova Dias Marisa, et al.
Health Promotion Journal of Australia : Official Journal of Australian Association of Health Promotion Professionals|September 5, 2020
Supporting patients to be involved in decisions about their health and care: Development of a best practice health literacy App for Australian adults living with Chronic Kidney DiseaseDanielle Marie Muscat, Kelly Lambert, Heather Shepherd, et al.
Pageof 28